Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineNo recent work listed

Xiao Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8354-9087; OpenAlex author ID A5073319973. Sources: OpenAlex.

Their work

Papers
11 (first author 4, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 4 papers · 2020: 1 paper · 2021: 3 papers

Papers 11

  1. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer. Co-author DOI 10.1016/j.jtemb.2021.126734↗
  2. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2147/ott.s296816↗
  3. Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.744667↗
  4. Differentiating hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma based on CT texture analysis. First author DOI 10.1177/0284185119875023↗
  5. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography. First author DOI 10.1371/journal.pone.0211566↗
  6. Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography. First author DOI 10.2147/cmar.s217033↗
  7. Pancreatic Ductal Adenocarcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis For Prediction Of Histopathological Grade. Co-author DOI 10.2147/cmar.s218414↗
  8. Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images. Co-author DOI 10.3389/fonc.2019.01171↗
  9. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis. Last author DOI 10.1186/s40644-018-0170-8↗
  10. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer. Co-author DOI 10.2147/ijn.s177993↗
  11. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced a… First author DOI 10.18632/oncotarget.17309↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhongqiu Wang · 8 shared papers, 2017–2021 · strength 0.80
  2. Shuai Ren · 6 shared papers, 2019–2021 · strength 0.67
  3. Rui Zhao · 3 shared papers, 2019–2021 · strength 0.33
  4. Zhonglan Wang · 3 shared papers, 2018–2020 · strength 0.33
  5. Wenli Qiu · 3 shared papers, 2018–2019 · strength 0.28
  6. Kai Guo · 2 shared papers, 2019–2021 · strength 0.23
  7. Rong Chen · 2 shared papers, 2019 · strength 0.20
  8. Xiaoling Zhuge · 2 shared papers, 2017–2018 · strength 0.16
  9. Chuangen Guo · 2 shared papers, 2017–2018 · strength 0.16
  10. Bo Zhu · 1 shared paper, 2021 · strength 0.16
  11. Zichun Hua · 1 shared paper, 2021 · strength 0.16
  12. Zhongqiu Wang · 1 shared paper, 2020 · strength 0.13
  13. Cheng Wang · 1 shared paper, 2021 · strength 0.13
  14. Xin Chen · 1 shared paper, 2021 · strength 0.13
  15. Yongkang Liu · 1 shared paper, 2021 · strength 0.13
  16. Jianhua Wang · 1 shared paper, 2021 · strength 0.13
  17. Zipeng Lu · 1 shared paper, 2021 · strength 0.13
  18. Tao Li · 1 shared paper, 2021 · strength 0.13
  19. Yingying Cao · 1 shared paper, 2021 · strength 0.13
  20. Zhongqiu Wang · 1 shared paper, 2019 · strength 0.11
  21. Jingjing Zhang · 1 shared paper, 2019 · strength 0.09
  22. Lina Song · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.